key: cord-0975499-dl0r1lk2 authors: Kutlu, Ömer; Güneş, Rıdvan; Coerdt, Kathleen; Metin, Ahmet; Khachemoune, Amor title: The effect of the “stay‐at‐home” policy on requests for dermatology outpatient clinic visits after the COVID‐19 outbreak date: 2020-05-27 journal: Dermatol Ther DOI: 10.1111/dth.13581 sha: 84bff3dd9ee3b8cd39d6ec0435ee6bbbaf29f0d0 doc_id: 975499 cord_uid: dl0r1lk2 The Coronavirus Disease 2019 (COVID‐19) emerged late in Turkey but it showed a rapid progression later. We aimed to investigate the changes in the number of patients who requested a dermatology outpatient clinic visit due to the increased social and medical burden caused by COVID‐19 in Turkey during the first days of the pandemic. We also examined the most common dermatologic diseases diagnosed during the COVID‐19 outbreak. A statistically significant negative correlation was found between the number of COVID‐19 patients in the country and the number of patients requesting a dermatology outpatient clinic visit in the secondary and tertiary care hospitals during self‐quarantine. In the first 10 days after the COVID‐19 outbreak, acne (28.2%), urticaria (12.8%), scabies (12.8%), irritant contact dermatitis (10.3%), and xerosis cutis (10.2%) were the most common diseases seen in the dermatology clinic at the secondary care hospital, while acne (23.3%), warts (5.4%), seborrheic dermatitis (4.5%), urticaria (3.8%), and psoriasis (3.32%) were the most common diseases seen in the dermatology clinic at the tertiary care hospital. This is our first study on the frequency and nature of outpatient dermatology visits during this novel coronavirus pandemic. Understanding the trends and impacts of dermatologic diseases on patients and health systems during this pandemic will allow for better preparation of dermatologists in the future. This study was carried out retrospectively by analyzing the numbers and diagnoses of patients who requested a visit to one of the dermatology outpatient clinics at Nevşehir State Hospital and Uşak Training and Research Hospital in Turkey. The first case of COVID-19 in Turkey was diagnosed on 11 March 2020. On March 21, 2020, Turkey imposed a partial curfew for citizens over the age of 65 and those with chronic diseases as part of measures against the coronavirus outbreak. Therefore, patients seen 10 days before and 10 days after the first case of COVID-19 were included in this study. The total number of patients seen before the COVID-19 outbreak was 1092 and 1433 in the secondary and tertiary care hospital, respectively, while 772 and 1114 were seen after the COVID-19 outbreak, respectively. The average number of patients seen 10 days before the first COVID-19 case in Turkey and the average number of patients seen in the 10 days after the first case were investigated ( Table 1) . The correlation between the number of patients requesting a visit to the dermatology clinic and the increasing number of COVID-19 cases was examined. The most common types of diseases or reasons for requesting a dermatology outpatient clinic visit in the 10 days before and after the first COVID-19 case were also analyzed. The data were evaluated in the SPSS 20.0 program and were considered statistically significant when P < .05. Spearman's rho correlation was used for not normally distributed data in continuous measurement variables. A statistically significant negative correlation was found between the In the first 10 days after the COVID-19 outbreak, acne (28.2%), urticaria (12.8%), scabies (12.8%), irritant contact dermatitis (10.3%), and xerosis cutis (10.2%) were the most common diseases seen in the dermatology clinic at the secondary care hospital, while acne (23.3%), warts (5.4%), seborrheic dermatitis (4.5%), urticaria (3.8%), and psoriasis (3.32%) were the most common diseases seen in the dermatology clinic at the tertiary care hospital ( Table 2 ). After the COVID-19 outbreak, the number of patients requesting a dermatology outpatient clinic visit decreased significantly in a short time. The effect of the "stay-at-home" policy also contributed to the decrease in the number of patients going to the hospital. 5 In this study, we found a strong inverse correlation between the number of patient cases and deaths due to COVID-19 and the number of Although the percentage of hospital visits for dermatological diseases decreased after the pandemic arose, the percentage of scabies-related visits increased during the COVID-19 outbreak. Severe pruritus and sleeplessness may explain why patients with scabies requested outpatient clinic visits despite the warnings and enforcement of the "stay-at-home" policy. Scabies has been called "the worst itch"; it has caused great epidemics in history as well as large negative impacts on social health systems. 10, 11 Severe pruritus and sleeplessness may explain why patients with scabies requested outpatient clinic visits despite the warnings and enforcement of the "stay-at-home" policy. Furthermore, acne was the most common disease among patients requesting a dermatology outpatient clinic visit after the COVID-19 outbreak. This may be due to the fact that acne is more common in adolescents, who are risk-taking individuals, and the fact that using isotretinoin requires continuity. Acne can have a significant psychosocial impact on patients, which leads to high rates of treatment compliance among acne patients; thus, these patients are likely to maintain their scheduled follow-up visits. 12 Additionally, it is well known that fatality rates in young adults with COVID-19 are low, hence continuing the adolescent patient referral stream by other physicians to the dermatology outpatient clinics. 13 One additional important point which should be addressed is the increasing number of acne The most common dermatologic diseases in secondary and tertiary care hospitals before and after the COVID-19 outbreak This is our first study on the frequency and nature of outpatient dermatology visits and the most common types of diseases seen during this novel coronavirus pandemic. Understanding the trends and impacts of dermatologic diseases on patients and health systems during this pandemic will allow for better preparation of health professionals, including dermatologists, in the future. COVID-19) Situation Report -63. World Health Organization Priorities for global health community in COVID-19 pandemic World Health Organization Emergency Dashboard. Coronavirus Disease 2019 (COVID-19). World Health Organization Turkish Republic Ministry of Health The effect of quarantine and isolation for COVID-19 in general population and dermatologic treatments A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther A meta-analysis of observational studies on the association of chronic urticaria with symptoms of depression and anxiety How I faced my coronavirus anxiety Dermatological diseases presented before COVID-19. Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? Dermatol Ther Scabies and pruritus-a historical review About itching and scabies. Pruritus in medical history-from ancient world to the French revolution How to increase adherence and compliance in acne treatment? A combined strategy of SMS and visual instruction leaflet Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China